Copyright (c) 2026 Publicaciones e Investigación

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
When the Publicaciones e Investigaciones Journal receives an original study or article from its author(s), whether by email, postal service, or the platforms available for said purpose, know that it may be published in physical or electronic formats in national or international archives, databases, or SIRES. As such, Publications and Research authorizes the reproduction and citation of said material, provided that the description of information is carried out in conformity with bibliographic norms, and mention the corresponding names, authors, article, issue, and pages. Publications and Research, in advance, expresses that the information, concepts, and methods are the responsibility of the author(s). As such, the UNAD does not have any influence whatsoever over that expressed in the manuscript.
Development and validation of a deep learning-based diagnostic support system for pulmonary nodule detection in computed tomography
Lung cancer remains the leading cause of cancer-related mortality worldwide, with approximately 2.5 million new cases and 1.8 million deaths in 2022. Early detection of pulmonary nodules on computed tomography (CT) significantly improves survival rates, yet manual review of hundreds of slices per study imposes a considerable workload and carries a risk of missing small lesions. This article aims to describe the development and validation of a computer-aided diagnostic support system for pulmonary nodule detection in CT images using deep learning techniques. The research was conducted as an applied and experimental study using the public LUNA16 and LIDC-IDRI datasets (888 CT studies). An ETL pipeline was implemented, including image normalization, slice preparation, and patient-level partitioning to prevent data leakage. Classification architectures (ResNet18, EfficientNet-B0) and a final YOLOv8 Triple Ensemble system with three-dimensional non-maximum suppression were comparatively evaluated. Results showed that patient-level analysis provides greater clinical utility than isolated slice-level evaluation. At patient level, the final system achieved 93.26% accuracy, 94.59% sensitivity, 91.04% specificity, 94.59% F1-score, and 0.928 AUC, outperforming conventional CAD systems and approaching the performance of specialized three-dimensional architectures. It is concluded that the developed tool shows potential as an experimental support system for prioritizing suspicious studies; however, external clinical validation is required before its use in healthcare settings.